NYSE$PHR
Phreesia Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Phreesia's second quarter of fiscal year 2024 financial performance reflected continued value delivery for clients and business scaling.
Phreesia announced its Q2 fiscal year 2024 results, with total revenue increasing by 26% to $85.8 million compared to the same period in the prior year. The average number of healthcare services clients increased by 24% to 3,445. Net loss was $36.8 million, and adjusted EBITDA was negative $11.5 million.
- Total revenue increased by 26% to $85.8 million compared to the same period in the prior year.
- The average number of healthcare services clients increased by 24% to 3,445 compared to the same period in the prior year.
- Healthcare services revenue per AHSC remained relatively flat at $18,268 compared to $18,248 in the same period in the prior year.
- Net loss was $36.8 million compared to $46.7 million in the same period in the prior year.
Headline financials
Revenue & EPS history
Phreesia · Revenue · Quarterly
$85.8M
Revenue by segment
Phreesia · $85.8M total across 3 segments · Q2 2024
- Subscription Services$39.3M+26.5%45.8%
- Payment Processing$23.6M+20.7%27.5%
- Network Solutions$22.9M—26.7%
Forward guidance
Phreesia is maintaining its revenue outlook for the full fiscal year 2024 at between $353 million and $356 million, implying year-over-year growth of 26% to 27%. They are raising their Adjusted EBITDA outlook for fiscal year 2024 to a range of negative $54 million to negative $49 million from a previous range of negative $60 million to negative $55 million.
Tailwinds
- Maintaining revenue outlook for fiscal year 2024 at between $353 million and $356 million, implying year-over-year growth of 26% to 27%.
- Raising Adjusted EBITDA outlook for fiscal year 2024 to a range of negative $54 million to negative $49 million from a previous range of negative $60 million to negative $55 million.
- Maintaining $500 million revenue target to be achieved by annualizing the highest-revenue quarter in fiscal year 2025.
- Continuing to expect to reach profitability during fiscal year 2025.
- Believing that cash and cash equivalents, along with cash generated in the normal course of business, can support the path to fiscal year 2025 targets.
Headwinds
- Adjusted EBITDA outlook has not been reconciled to GAAP Net income (loss).
- Uncertainty and potential variability of Other (income) expense, net and (Benefit from) provision for income taxes.
- Inability to reasonably predict such items.
- Items could have a significant impact on the calculation of GAAP Net income (loss).
- Maintaining Adjusted EBITDA outlook for fiscal year 2024 to a range of negative $54 million to negative $49 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2024
-1.6%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+2.0%
Avg return
30 days after
54%
15 / 28 earnings
Positive
+21.4%
Q2 2023
Best reaction
-26.3%
Q4 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -26.3% | -1.1% | — | |
| Q1 2027 | +2.3% | +13.3% | — | |
| Q3 2026 | -22.8% | -19.2% | -16.0% | |
| Q2 2026 | -9.8% | -18.8% | -25.4% | |
| Q1 2026 | -6.6% | -0.2% | +14.2% | |
| Q4 2025 | +6.9% | +14.6% | +1.1% | |
| Q3 2025 | +11.1% | +14.8% | +30.8% | |
| Q2 2025 | +7.9% | +0.5% | -6.8% | |
| Q1 2025 | -13.3% | -14.7% | -2.9% | |
| Q4 2024 | +1.7% | -0.7% | +1.0% | |
| Q3 2024 | +17.8% | +18.8% | +45.2% | |
| Q2 2024 | -21.2% | -27.1% | -39.1% | |
| Q1 2024 | +3.6% | +10.3% | +4.0% | |
| Q4 2023 | -13.5% | -10.0% | -5.7% | |
| Q3 2023 | +18.7% | +34.8% | +20.0% | |
| Q2 2023 | +21.4% | +28.2% | +4.9% | |
| Q1 2023 | +11.9% | +17.5% | +40.1% | |
| Q4 2022 | -11.9% | +1.3% | -23.6% | |
| Q3 2022 | -20.2% | -20.9% | -32.9% | |
| Q2 2022 | -12.4% | -6.2% | -15.4% | |
| Q1 2022 | +6.6% | +12.7% | +24.2% | |
| Q4 2021 | +2.5% | +8.4% | +3.3% | |
| Q3 2021 | +7.3% | +18.1% | +16.2% | |
| Q2 2021 | -3.2% | -9.2% | +3.5% | |
| Q1 2021 | -6.7% | -10.5% | -13.1% | |
| Q4 2020 | +4.2% | +18.1% | +30.6% | |
| Q3 2020 | -1.0% | -8.8% | -6.9% | |
| Q2 2020 | +0.2% | +7.3% | +1.2% | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro